Founded by survivors, CardioPath provides lab services for the diagnosis of unexplained heart disease. CardioPath is the first comprehensive lab in the US providing histology, immunohistology and molecular testing via endomyocardial biopsy in a simple all in 1 approach.
About Fulgent Genetics
Fulgent Genetics is a full-service genomic testing company built around a foundational technology platform. Through this platform, Fulgent has built a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy, and competitive turnaround times. By combining these comprehensive testing options with excellent service and support, Fulgent aims to redefine the way medicine is managed for patients and clinicians alike.
GeneDx, Inc. is a global leader in genomics, providing advanced testing to patients and their families. Originally founded by scientists from the National Institutes of Health, GeneDx offers a world-renowned clinical genomics program with particular expertise in rare and ultra-rare genetic disorders. In addition to its market-leading exome sequencing service, GeneDx provides a comprehensive suite of additional genetic testing services.
In April 2022, GeneDx was acquired by Sema4, a patient-centered health intelligence company. The combined company is focused on accelerating the use of genomics and leveraging large-scale clinical data to enhance the standard of care through extensive precision medicine solutions.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Invitae Corporation is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to support improved healthcare for billions of people. Invitae’s goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time and low prices.
About PerkinElmer Genomics
PerkinElmer Genomics is a global leader in genetic and genomic testing focused on rare diseases, inherited disorders, newborn screening, and hereditary cancer. Our services support the full continuum of care from preconception and prenatal to neonatal, pediatric, and adult. Testing options include sequencing for targeted genes, multiple genes, the whole exome or genome, and copy number variations. Using a simple saliva or blood sample, we answer complex genetic questions that can proactively inform patient care and end the diagnostic odyssey for families.